- Functional Magnetic Resonance Imaging
- Computed Tomography
- Positron Emission Tomography
- Electro Encephalography
- Magneto Encephalography
- Near Infrared Spectroscopy
Brain Imaging and Neuroimaging Market size was valued at USD 35,476.7 million in 2022 and is expected to grow at a 5.9% CAGR from 2023 to 2029. The rising prevalence of neurological disorder, along with the growing geriatric population who are more prone to develop neurological disorder or neurodegenerative disease like Alzheimer’s, epilepsy, Parkinson’s, dementia, and others is expected to drive the growth of brain imaging & neuroimaging market over the forecasted period. In addition, rising new technological advancements and growing investments in research and development is expected to boost the market growth. Furthermore, rising incidence of brain cancer, and increasing number of road accidents across the globe is expected to further fuel the growth of brain imaging and neuroimaging market over the forecasted period. Moreover, rising disease prevalence and awareness in North America region is expected to provide opportunity key market players over the forecasted period. For instance, according to Parkinson’s foundation almost one million people was suffering from Parkinson’s Disease in 2020, and each year about 60,000 Americans are diagnosed with Parkinson’s disease. Whereas, on the other side high cost of brain imaging and neuroimaging devices is expected to hinder the market growth over the forecasted period. However, the leading key market companies are focused in developing new advanced technological portable brain scanner which are expected to revolutionize the brain imaging by reducing the cost of treatment making the easily accessible by all. For instance, researchers in EM Vision medical devices have developed a portable brain scanner technology which enables to scan brain from any location. However, the high cost of imaging devices is expected to hinder the market growth over the forecast period.
In March 2018, Nihon Kohden launched Aireeg WEE-1200, a wireless EEG system to provide real time in epilepsy monitoring.
Fastest Growing Market
The brain imaging and neuroimaging market is expected to grow over the forecasted period due to the increasing prevalence of neurodegenerative disorders and increasing geriatric population who are more prone to develop neurological disorders. According to research study, about 10 to 20 in every 1000 people are diagnosed with neurological disorders like Parkinson’s, Alzheimer’s, epilepsy each year. In addition, innovation of new technology and development of portable brain monitoring devices is expected to fuel the market growth over the forecasted period. For instance, researchers in EM Vision medical devices have developed a portable brain scanner technology which enables it to scan brain from any location.
Brain Imaging and Neuroimaging market was valued at USD 35,476.7 million in 2022 and is expected to grow at a 5.9% CAGR from 2023 to 2029.
Increasing prevalence of neuro degenerative disorders, road accidents, brain tumor are expected to drive the market growth.
The leading players in the global Brain Imaging and Neuroimaging market are Varian medical Systems, General Electric Company, Siemens AG, Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Sanrad medical Systems Pvt. Ltd, Esaote SpA, MinFound Medical Systems Co ltd, NeuroSoft, Medtronic Plc.
North America Brain imaging and neuroimaging market is expected to dominate the market over the forecast years.